ASCRS Innovation Lecture 2019: A Novel Non-Penetrating Keratoprosthesis as a Solution for Global Corneal Blindness

ASCRS Innovation Lecture 2019: A Novel Non-Penetrating Keratoprosthesis as a Solution for Global Corneal Blindness

Yichieh Shiuey, MD and Jose M. Vargas, MD

The KeraKlear Artificial Cornea has not received FDA Clearance ​
and is limited by U.S. Law to Investigational Use Only​

The KeraKlear has European CE Mark Approval

Development of the KeraKlear was Funded in Part by the ​
US National Institutes of Health and the National Eye Institute

Download the presentation by clicking here.